medigraphic.com

2004, Número 3

<< Anterior Siguiente >>

Cir Cir 2004; 72 (3)


Síndrome doloroso regional complejo. Estado actual

Díaz-Zuluaga PA, Plancarte-Sánchez R, Tamayo-Valenzuela AC

Idioma: Español
Referencias bibliográficas: 84
Paginas: 225-238
Archivo PDF: 121.94 Kb.


RESUMEN

El síndrome doloroso regional complejo es un desorden o grupo de desórdenes que pueden desarrollarse como consecuencia de un trauma, con o sin una lesión nerviosa obvia. Se caracteriza por dolor espontáneo, hiperalgesia y alodinia, anormalidades sensoriales, alteración del flujo sanguíneo, de la sudoración y cambios tróficos; así como por un estado agudo con síntomas de inflamación regional y por un estado crónico de desórdenes neuropáticos. El dolor se asocia a los cambios generados por el sistema nervioso autónomo. Las neuronas espinales pueden aumentar su sensibilidad por los cambios anatómicos. A nivel supraespinal se observa reorganización de la corteza somatosensorial. El establecimiento de criterios diagnósticos ha sido difícil dada la variedad del cuadro de esta patología. La inhibición simpática con fentolamina es la prueba más aceptada para diagnosticar un dolor de mantenimiento simpático. Aunque diversas estrategias han sido empleadas para el manejo de síndrome doloroso regional complejo, con ninguna se han obtenidos resultados contundentes.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Hicks M. Complex regional pain syndrome: a new name for reflex sympathetic dystrophy. In: Aronoff GM, editor. Evaluation and treatment of chronic pain. Baltimore MD, USA: Lippincott Williams & Wilkins; 1999; pp. 191-198.

  2. Jänig W. CRPS-I and CRPS-II: a strategic view. In: Harden N, Baron R, Jänig W, editors. Complex regional pain syndrome. Progress in pain research and management. Seattle, WA, USA: IASP Press; 2001. pp. 3-15.

  3. Birklein F, Handwerker O. Síndrome de dolor regional complejo: ¿cómo resolver la complejidad? Rev Soc Esp Dolor 2003;10:32-39.

  4. Rho R, Brewer R, Lamer T. Complex regional pain syndrome. Mayo Clin Proc 2002;77:174-180.

  5. Steinbrocker O. The shoulder-hand syndrome in reflex dystrophy of the upper extremity. Ann Intern Med 1948;29:22-52.

  6. Weiskopf R. Complex regional pain syndrome I (reflex sympathetic dystrophy). Anesthesiology 2002;96:1254-1260.

  7. Stanton-Hicks M, Burton A, Bruehl S. An update interdisciplinary clinical pathway for CRPS: Report of an Expert Panel. Pain Practice 2002;1:1-16.

  8. Allen G, Galer BS, Schwartz L. Epidemiology of complex regional pain syndrome: a retrospective chart review of 134 patients. Pain 1999;80:539-544.

  9. Plancarte R, Calvillo O. Complex regional pain syndrome type 2 (causalgia) after automated laser discectomy. A case report. Spine 1997;22:459-462.

  10. Veldman P, Reynan HM, Amtz LE. Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients. Lancet 1993;342:1012-1016.

  11. Lynch ME. Psychological aspects of reflex sympathetic dystrophy: a review of the adult and pediatric literature. Pain 1992;49:337-347.

  12. Harden N. A clinical approach to complex regional pain syndrome. Clin J Pain 2000;16:S26-S32.

  13. Oerlemans M, Oostendorp R, de Boo T. Signs and symptoms in complex regional pain syndrome type I/reflex sympathetic dystrophy: judgment of the physician versus objective measurement. Clin J Pain 1999;15:224-232.

  14. Birklein F, Riedl B, Sieweke N. Despite clinical similarities there are significant differences between acute limb trauma and complex regional pain syndromes- analysis of 145 cases. Acta Neurol Scand 2000;101:262-269.

  15. Appelboom T. Calcitonin in reflex sympathetic dystrophy syndrome and other painful conditions. Bone 2002;30:84S-86S.

  16. Galer BS, Jensen M. Neglect-like symptoms in complex regional pain syndrome: results of a self-administered survey. J Pain Symptom Manage 1999;18:213-217.

  17. Jahangir M, Alissa A, Bennett G, Schwartzman RJ. Patterns of spread in complex regional pain syndrome, type I (reflex sympathetic dystrophy). Pain 2000;88:259-266.

  18. Huygen F, de Bruijn A, Klein J. Neuroimmune alterations in the complex regional pain syndrome. Eur J Pharmacol 2001;429:101-113.

  19. Birklein F, Rield B, Sieweke N, Weber M. Neurologic findings in complex regional pain syndromes-analysis of 145 cases. Acta Neurol Scand 2000;101:262-269.

  20. Drummond P, Finch P, Smythe G. Reflex sympathetic dystrophy: the significance of differing plasma cathecholamine concentrations in affected and unaffected limbs. Brain 1991;114:2025-2035.

  21. Galer B, Butler S, Jensen M. Case reports and hypothesis: a neglect-like syndrome may be responsible for the motor disturbance in reflex sympathetic dystrophy (complex regional pain syndrome-I). J Pain Symptom Manage 1995;10:385-391.

  22. Trigs W, Gold M, Adair J, Heilman K. Motor neglect associated with a discrete parietal lesion. Neurology 1994;40:57-61.

  23. Butler S. Disuse and CRPS. In: Harden N, Baron R, Jänig W, editors. Complex regional pain syndrome. Progress in pain research and management. Seattle, WA, USA: IASP Press; 2001. pp. 141-150.

  24. Koerber HR, Mirnics K, Brown PB. Central sprouting and functional plasticity of regenerated primary afferents. J Neurosci 1994;80: 3655-3671.

  25. Ribbers GM, Geurts AC, Stam HJ. Pharmacologic treatment of complex regional pain syndrome I: a conceptual framework. Arch Phys Med Rehabil 2003;84:141-146.

  26. Thimineur M, Sood P, Kravitz E. Central nervous system abnormalities in complex regional pain syndrome (CRPS): clinical and quantitative evidence of medullary dysfunction. Clin J Pain 1998;14:256-267.

  27. Maihöfner C, Handewerker HO, Neudörfer B. Patterns of cortical reorganization in complex regional pain syndrome. Neurology 2003; 61:1707-1715.

  28. Díaz-Zuluaga PA, Zea MV, Guevara UM. Resolución de un caso de SDRC con neuroestimulador cortical tipo “Gris”. IV Congreso Internacional de la Asociación Mexicana para Estudio y Tratamiento del Dolor (AMETD) y Cuidados Paliativos. Huatulco, Oaxaca, México, 17 a 20 de noviembre, 2000.

  29. Bruehl S. Do psychological factors play a role in the onset and maintenance of CRPS-I In: Harden N, Baron R, Jänig W, editors. Complex regional pain syndrome. Progress in pain research and management. Seattle, WA, USA: IASP Press; 2001. pp. 279-290.

  30. Monti DA, Herring CL, Schwartzman RJ, Marchese M. Personality assessment of patients with complex regional pain syndrome type I. Clin J Pain 1998;14:295-302.

  31. Geertzen JH, de Bruijn-Kofman AT, de Bruijn HP. Stressful life events and psychological dysfunction in complex regional pain syndrome type I. Clin J Pain 1998;14:143-147.

  32. Lembeck F, Holzer P. Substance P as a neurogenic mediator of antidromic vasodilatation and neurogenic plasma extravasation. Naumyn-Schmiedeberg’s Arch Pharmacol 1979;310:175-183.

  33. Brain S, Tippins J, Morris H. Potent vasodilator activity of calcitonin gene-related peptide in human skin. J Invest Dermatol 1986;87:533-536.

  34. Coderre T, Basbaun A, Levine J. Neural control of vascular permeability: interactions between primary afferents, mast cells and sympathetic efferents. J Neurophysiol 1989;62:48-58.

  35. Calixto J, Cabrini D, Ferreira J, Campos M. Kinins in pain and inflammation. Pain 2000;87:1-5.

  36. Nilsson S, Mäepea O. Comparison of the vasodilatory effects of vasoactive intestinal polypeptide (VIP) and peptide HI (PHI) in the rabbit and the cat. Acta Physiol Scand 1987;129:17-36.

  37. Nichols M, Allen B, Rogers S. Transmission of chronic nociception by spinal neurons expressing the substance P receptor. Science 1999; 286:1558-1561.

  38. Khalil Z, Helme R. Serotonin modulates substance P-induced plasma extravasation and vasodilation in rat skin by an action through capsaicin-sensitive primary afferent nerves. Brain Res 1990;527:292-298.

  39. Phan T, Lafforgue P. Reflex sympathetic dystrophy syndrome and neuromediators. Joint Bone Spine 2003;70:12-17.

  40. Wilson PR, Low PA, Bedder MD. Diagnostic algorithm for complex regional pain syndrome In: Jänig W, Stanton-Hicks M, editors. Reflex sympathetic dystrophy: a reappraisal. Progress in pain research and management. Vol. 6. Seattle, WA, USA: IASP Press; 1996. pp. 93-106.

  41. Guzmán M. Distrofia simpático refleja. Rev Colomb Reumatol 1998;5:27-40.

  42. Kozin F. Painful shoulder and the reflex sympathetic dystrophy syndrome. In: McCarty DJ, Koopman WJ, editors. Arthritis and allied conditions. 13th ed. Philadelphia, PA, USA: Lea and Febiger; 1997. pp. 1887-1922.

  43. Raja SN, Treede R, Davis KD, Campbell JN. A diagnostic test for sympathetically maintained pain. Anesthesiology 1991;74:691-698.

  44. Campbell JN, Raja SN, Selig DK, Beizberg AJ. Diagnosis and management of sympathetically maintained pain. In: Fields HD, Leibeskind J, editors. Progress in pain research and management. Vol. 1. Seattle. WA, USA: IASP Press; 1994. pp. 85-100.

  45. Price D, Long S, Wilsey B, Rafii A. Analysis of peak magnitude and analgesia produced by local anesthetics injected into sympathetic ganglion of complex regional pain syndrome patients. Clin J Pain 1998;14:216-226.

  46. Gulevich SJ, Conwell TD, Lane J. Stress infrared thermography is useful in the diagnosis of complex regional pain syndrome type I. Clin J Pain 1997;13:50-59.

  47. Robaina FJ, Miranda G. Avances en el diagnóstico y tratamiento del dolor de origen simpático. Rev Soc Esp Dolor 2000;7:390-402.

  48. Bruehl S, Lubenow TR, Nath H. Validation of thermography in the diagnosis of reflex sympathetic dystrophy. Clin J Pain 1996;12:316-325.

  49. Sandroni P, Low PA, Ferrer T, et al. Complex regional pain syndrome I (CRPS I): prospective study and laboratory evaluation. Clin J Pain 1998;14:282–9.

  50. Verdugo R, Ochoa J. Quantitative somatosensory thermotest. A key method for functional evaluation of small caliber afferent channels. Brain 1992;115:893-913.

  51. Kozin F, Soin JS, Ryan LM. Bone scintigraphy. The reflex sympathetic dystrophy syndrome. Radiology 1981;138:437-443.

  52. Staton-Hicks M, Baron R, Boas R. Complex regional pain syndromes: guidelines for therapy. Clin J Pain 1998;14:155-166.

  53. Watson C. The treatment of neuropathic pain: antidepresants and opioids. Clin J Pain 2000;16(Suppl 2):S49-S55.

  54. Mellick G, Melliey L, Mellick L. Gabapentin in the management of reflex sympathetic dystrophy. J Pain Symptom Manage 1995;10: 265-266.

  55. Watson C, Babul N. Efficacy of oxicodone in neuropathic pain: a randomized controlled trial in postherpetic neuralgia. Neurology 1998;50:1837-1841.

  56. Harati Y, Gooch C, Swenson M, et al. Doubled-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998;50:1842-1846.

  57. Sindrup S, Adersen G, Madsen C, et al. Tramadol relieves pain and allodynia polyneuropathy: a randomized, double blind, controlled trial. Pain 1999;83:85-90.

  58. Garner-Nix J. Oral methadone for managing chronic non-malignant pain. J Pain Symptom Manage 1996;11:321-328.

  59. Hays H. Use of methadone in treating non cancer pain. Pain Res Manage 1999;4:23-27.

  60. Altier N, Dion D, Boulanger A, Choinière M. Successful use of methadone in the treatment of chronic neuropathic pain arising from pain injuries: a case study. Burns 2001;27:771-775.

  61. Christensen K, Jensen E, Noer I. The reflex dystrophy syndrome response to treatment with systemic corticosteroid. Acta Chir Scan 1982;148:653-655.

  62. Takahiro U, Toshikazu T, Tetsuya K, et al. Analgesic effects of ketamine ointment in patients with complex regional pain syndrome type 1. Reg Anesth Pain Med 2002;27:524-528.

  63. Cheshire WP, Snyder CR. Treatment of reflex sympathetic dystrophy with topical capsaicin: case report. Pain 1990;42:307-311.

  64. Wang JK, Keneth AJ, Ilstrup D. Sympathetic blocks for reflex sympathetic dystrophy. Pain 1985;23:13-17.

  65. Hogan Q, Abram S. Neural blockade for diagnosis and prognosis. A review. Anesthesiology 1997;86:216-241.

  66. Cepeda MS, Joseph Lau, Carr DB. Defining the therapeutic role of anesthetic blockade in complex regional pain syndrome: a narrative and systematic review. Clin J Pain 2002;18:216-233.

  67. Boas R. Sympathetic nerve blocks: in search of a role. Reg Anesth Pain Med 1998;23:292-305.

  68. Shealy CN, Mortimer JT, Reswick JB. Electrical inhibition of pain by stimulation of the dorsal columns: preliminary clinical report. Anesth Analg 1967;46:489-491.

  69. Melzack R, Wall P. Pain mechanisms, a new theory. Science 1965;150: 971-979.

  70. Krames E. Mechanisms of action of spinal cord stimulation. In: Waldman S, editor. Interventional pain management. Philadelphia, PA, USA: W.B. Saunders Company; 2001. pp. 561-565.

  71. Gybels J, Erdine S, Maeyaert J, et al. Neuromodulation of pain. A consensus statement prepared in Brussels, Belgiumm 16-18 January 1998 by the following Task Force of the European Federation of IASP Chapters (EFIC). Eur J Pain 1998;2:203-209.

  72. Grabow T, Tella P, Raja S. Spinal cord stimulation for complex regional pain syndrome. An evidence based medicine review of the literature. Clin J Pain 2003;19:371-383.

  73. Kelmer MA, Barendese G, van Kleef M, et al. Spinal cord stimulation in patients with chronic reflex sympathetic dysthrophy. N Engl J Med 2000;343:618-624.

  74. Krames E. Implantable devices for pain control: spinal cord stimulation and intrathecal therapies Best Pract Res Clin Anesthesiol 2002;16: 936-949.

  75. Bennett G, Burchiel K, Buchser E, et al. Clinical guidelines for intraspinal infusion: Report of an Expert Panel. J Pain Symptom Manage 2000;20:S37-S43.

  76. Moufawad S, Malak O, Mekhail N. Epidural infusion of opiates and local anesthetics for complex regional pain syndrome. Pain Practice 2002;2:81-86.

  77. Kiowki W, Hulthen U, Martin T, Eisenach J. Pharmacology of non opioid analgesic in chronic pain states. J Pharmacol Exp Ther 2001;299:811-817.

  78. Martin T, Eisenach J. Pharmacology of non opioid analgesic in chronic pain states. J Pharmacol Exp Ther 2001;299:811-817.

  79. Rauck RL, Eisenach JC, Jackson K, Young LD, Southern J. Epidural clonidine treatment for refractory reflex sympathetic dystrophy. Anesthesiology 1993;79:1163-1169.

  80. Van Hilten J, Van de Beek W, Hoff J, et al. Intrathecal baclofen for the treatment of dystonia in patients with reflex sympathetic dystrophy. N Engl J Med 2003;343:625-630.

  81. Zúñiga R, Perera S, Abram S. Intrathecal baclofen: a useful agent of well established complex regional pain syndrome. Reg Anesth Pain Med 2002;27:90-93.

  82. Takahashi H, Miyazaki M, Nanbu T, et al. The NMDA-receptor antagonist ketamine abolishes neuropathic pain after epidural administration in a clinical case. Pain 1998;75:391-394.

  83. Lin T-C, Wong C-S, Chen F-C, et al. Long-term epidural ketamine, morphine and bupivacaine attenuate reflex sympathetic dystrophy neuralgia. Can J Anaesth 1998;45:175-177.

  84. Wallace MS. Calcium and sodium channel antagonists for the treatment of pain. Clin J Pain 2000;16:S80-S85.




2020     |     www.medigraphic.com